BCLI BrainStorm Cell Therapeutics Inc.: Expected earnings per share growth for next year
The EPS projections for Brainstorm Cell (BCLI) for the coming year demonstrate that the current metric is 10.10. The potential of Brainstorm Cell is based on the unique NurOwn method for combating paralysis. However, financial stability currently relies on external investments and grants. Massive demand for ALS therapy makes the business promising, provided it receives regulatory approval.
Analytical breakdowns for Brainstorm Cell
- price and consensus price forecast:
- company stock capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Debt to Equity Brainstorm Cell|BCLI - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio BrainStorm Cell Therapeutics|BCLI - Aggregate Debt Obligations|Debts to Book Capitalization BrainStorm Cell Therapeutics|BCLI - Company Long-Term Liabilities|Company Short-Term Debts BrainStorm Cell Therapeutics|Quick Liquidity brainstorm-cell.com
- net income and valuation ratios data:
BCLI - Company Net Income|Expected Profit Brainstorm Cell|BCLI - Price to Earnings Ratio|Forward P/E Multiple Brainstorm Cell|BCLI - Price/Earnings to Growth Ratio|EV/EBITDA Multiple BrainStorm Cell Therapeutics|BCLI - Operating profit before deduction of amortization|Earnings per share for the last twelve months BrainStorm Cell Therapeutics|BCLI - Earnings per share for the last twelve months|Quarterly EPS earnings growth brainstorm-cell.com|BCLI - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Brainstorm Cell
Fundamental company valuation:Brainstorm Cell Therapeutics, Inc., BCLI
The monetization of the NurOwn platform and its patent portfolio in the therapy of neurological diseases directly determines the future profitability of Brainstorm Cell (BCLI). This indicator aggregates analysts' consensus forecasts for profit growth rates over the coming period, allowing investors to assess market expectations for the commercialization of these technologies. Analyzing the current trajectory of next year's EPS forecasts helps identify whether the asset is overvalued or possesses hidden growth potential.
Analysis of competing companies
Net earnings per share growth forecast for next year Biogen Corp|Neurocrine Corp (NBIX) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year RGC (Regencell Bioscience)|Projected earnings per share increase next year AXSM|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Xenon Pharmaceuticals Inc. (XENE) - Expected net earnings per share growth next year|VKTX - Net earnings per share growth forecast for next year|Expected earnings per share trend next year SUPN (Supernus Corp)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year denalitherapeutics.com|Expected earnings per share growth for next year HRMY|BHVN: Expected earnings per share trend next year|Earnings growth forecast for next year AMLX|Expected earnings per share growth for next year Trevi Corp TRVI|Earnings growth forecast for next year PRAX (Praxis Precision Medicines)|anavex.com (AVXL) - Expected net earnings per share growth next year|CBLL - Net earnings per share growth forecast for next year|PRTA: Net earnings per share growth forecast for next year|alector.com (ALEC) - Net earnings per share growth forecast for next year|ANNX (Annexon Biosciences Inc.) - Net earnings per share growth forecast for next year|OMER (Omeros Corp) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year NGNE|Earnings growth forecast for next year ACIU|Expected earnings per share growth for next year Voyager Therapeutics Inc VYGR|Net earnings per share growth forecast for next year Neumora Therapeutics Inc NMRA|Scilex Holding Company, Inc. - Net earnings per share growth forecast for next year|Tevogen Bio Holdings - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Alpha Cognition ACOG|Cognition Therapeutics (CGTX) - Net earnings per share growth forecast for next year|Projected earnings per share growth rate for next year IKT|SAVA (Cassava) - Earnings growth forecast for next year|Expected net earnings per share growth next year Assertio Therapeutics ASRT|Expected earnings per share growth for next year COYA (Coya Therapeutics, Inc.)|Earnings growth forecast for next year vistagen.com (VTGN)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|Expected earnings per share trend next year ABOS|CRVO - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Alterity Therapeutics|CLNN: Earnings growth forecast for next year|PEPG (PepGen) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|RLMD: Expected earnings per share trend next year|Earnings growth forecast for next year ANVS|Earnings growth forecast for next year gracetx.com (GRCE)|Earnings growth forecast for next year AIFF (Firefly Neuroscience, Inc)|Consensus forecast of earnings per share growth for next year ANEW Medical (KLTO)|NRSN - Net earnings per share growth forecast for next year|RVPH (Reviva Pharmaceuticals Holdings Inc.) - Projected earnings per share growth rate for next year|metaviatx.com (MTVA) - Net earnings per share growth forecast for next year|NRXS - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year HSDT|PASG (Passage Bio Corp) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year Neuphoria Therapeutics Inc. (NEUP)|NERV - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Athira ATHA|Expected earnings per share trend next year ADXN|ALZN - Net earnings per share growth forecast for next year|Cyclerion Therapeutics (CYCN) - Expected earnings per share growth for next year|PTIX (protagenic.com) - Expected earnings per share growth for next year|Pasithea Therapeutics Corp. - Expected earnings per share trend next year|CRGT (Cortigent Inc) - Earnings growth forecast for next year|Expected earnings per share growth for next year Avenue Therapeutics Inc (ATXI)|Earnings growth forecast for next year CARA|CHRO - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Eliem Therapeutics Inc. ELYM|Intra-Cellular Therapies Inc. - Net earnings per share growth forecast for next year|LBPH - Net earnings per share growth forecast for next year|MRNS: Net earnings per share growth forecast for next year|NKGN: Earnings growth forecast for next year|NRBO (neurobopharma.com) - Net earnings per share growth forecast for next year|SAGE (Sage Therapeutics) - Earnings growth forecast for next year|Expected earnings per share growth for next year Synaptogenix Inc. (SNPX)|Net earnings per share growth forecast for next year Trevena, Inc (TRVN)|Net earnings per share growth forecast for next year VIGL (vigilneuro.com)|Earnings growth forecast for next year WENA (Anew Medical)|Consensus forecast of earnings per share growth for next year cerevel.com (CERE)
